NASDAQ

Cartesian Therapeutics, Inc. (RNAC)

♥ 524 Thanks from members

Live price chart, market sentiment, and community perspectives for Cartesian Therapeutics, Inc. (NASDAQ: RNAC).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Cartesian Therapeutics Scientific FoundersLeadership: Murat Karayalcin (President and CEO)Leadership: Milton Jacobs (CFO)Holder: RA Capital ManagementHolder: Polaris PartnersHolder: Vida VenturesHolder: Cartesian ExecutivesDescartes-08Descartes-15RNA-engineered CAR-T cell therapies#RNAC#Cartesian Therapeutics#NASDAQ RNAC#RNA Cell Therapy#Autoimmune Biopharma